Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
BridgeBio Pharma, Inc. (BBIO)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.1 | 0.0 | 0.1 | | |
|
Returns on Capital |
ROIC (including intangibles) | | | | -908.8% | |
ROE | | | | -43.5% | |
ROA | | | | -35.3% | |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 | 25.6 | | |
Days payables outstanding | 1,586.0 | 6.8 | 10.7 | | |
Cash conversion cycle | -1,586.0 | -6.8 | 14.9 | | |
|